Astellas, Pantherna add organ to mRNA tie-up; Rocket launches sale of six figures worth of stock

Astellas and Pantherna have expanded their November 2021 pact surrounding the latter’s mRNA platform to include a new target organ, the duo announced Tuesday morning, though they did not specify what that target is.